Latest California Healthline Stories
Newsletter editor Brianna Labuskes wades through hundreds of health articles from the week so you don’t have to.
Innovations to help consumers manage their health were on display at the nation’s largest health technology conference that attracted more than 40,000 health industry professionals to Orlando.
The “Medicare–for-all” debate is already in full swing, but what does that phrase even mean? Joanne Kenen of Politico, Paige Winfield Cunningham of The Washington Post and Rebecca Adams of CQ Roll Call join KHN’s Julie Rovner for a beginner’s guide to the next big health policy debate. For “extra credit,” the panelists provide their favorite health policy stories of the week, and as a special Valentine’s Day bonus, their favorite #HealthPolicyValentines.
A significant portion of syphilis transmission in heterosexuals occurs among people who use drugs, particularly methamphetamine, a new report shows. Public health officials warn that you can’t treat one problem without addressing the other.
A new study examines how seniors with deteriorating strength and other physical functions deal with such challenges as taking a shower or getting dressed in the morning.
Unwilling to wait for federal action, California Gov. Gavin Newsom says he has a plan that could extract discounts from drugmakers and save the state money — one he hopes other states can join.
President Donald Trump wants Congress to allot $500 million over 10 years for pediatric cancer research. While it’s welcomed by researchers and advocates, it’s not a lot of money.
Federal officials regulate the handling of vaccines that are provided through the Vaccines for Children program, which offers the medicines generally for children whose families could not afford them. But there is no federal oversight of how these drugs are stored among other health care providers.
Columnist Judith Graham speaks with Sarah Szanton, director of the Center for Innovative Care in Aging at Johns Hopkins School of Nursing, about helping people age with independence.
The race for the cure to aging sparks hope and hype among top scientists — plus billions of dollars in investment.